 |
|
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clin Mol Hepatol. 2021;27(1):22-43. Published online 2020 Dec 10 DOI: https://doi.org/10.3350/cmh.2020.0129
|
|
Citations to this article as recorded by
 Elevated serum levels of diamine oxidase, D-lactate and lipopolysaccharides are associated with metabolic-associated fatty liver disease
Ruike Zhang, Ya-nan Chen, Jixia Zhang, Jing Liu
European Journal of Gastroenterology & Hepatology.2023; 35(1): 94. CrossRef Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
Ming Yang, Xiaoqiang Qi, Nan Li, Jussuf T. Kaifi, Shiyou Chen, Andrew A. Wheeler, Eric T. Kimchi, Aaron C. Ericsson, R. Scott Rector, Kevin F. Staveley-O’Carroll, Guangfu Li
Nature Communications.2023;[Epub] CrossRef The identification of metabolites from gut microbiota in NAFLD via network pharmacology
Ki-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung Min Won, Jin Ju Jeong, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Min Kyo Jeong, Ji Ye Hyun, Jung A Eom, Hee Jin Park, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Scientific Reports.2023;[Epub] CrossRef Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clinical and Molecular Hepatology.2023; 29(Suppl): S58. CrossRef The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Nieß, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin, Jens Werner, Florian Kühn
Journal of Gastrointestinal Surgery.2022; 26(3): 671. CrossRef Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, Stefano Bonapace, Tracey G. Simon, Giovanni Targher
Journal of the American College of Cardiology.2022; 79(2): 180. CrossRef Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi
Livers.2022; 2(1): 30. CrossRef Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
Byoungduck Han, Gyu Bae Lee, Sun Young Yim, Kyung-Hwan Cho, Koh Eun Shin, Jung-Hwan Kim, Yong-Gyu Park, Kyung-Do Han, Yang-Hyun Kim
Diagnostics.2022; 12(3): 663. CrossRef Pterostilbene and Its Derivative 3′-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway
Hui-Yun Tsai, Yu-Yuan Shih, Yao-Tsung Yeh, Cheng-Hsieh Huang, Chorng-An Liao, Chun-Yi Hu, Kalyanam Nagabhushanam, Chi-Tang Ho, Yu-Kuo Chen
Journal of Agricultural and Food Chemistry.2022; 70(16): 4966. CrossRef The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats
Yufan Dai, Wenyu Zhu, Jiaxuan Zhou, Tao Shen
Brazilian Journal of Medical and Biological Research.2022;[Epub] CrossRef Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak
Hepatology.2022; 76(6): 1746. CrossRef The Role of Rumen Microbiota and Its Metabolites in Subacute Ruminal Acidosis (SARA)-Induced Inflammatory Diseases of Ruminants
Yunhe Fu, Yuhong He, Kaihe Xiang, Caijun Zhao, Zhaoqi He, Min Qiu, Xiaoyu Hu, Naisheng Zhang
Microorganisms.2022; 10(8): 1495. CrossRef Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms
Ranran Zhang, Hongna Mu, Ziyun Li, Jie Zeng, Qi Zhou, Hongxia Li, Siming Wang, Xianghui Li, Xianghui Zhao, Liang Sun, Wenxiang Chen, Jun Dong, Ruiyue Yang
Frontiers in Microbiology.2022;[Epub] CrossRef Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
Hepatology Research.2022; 52(12): 975. CrossRef The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yu-Lin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, Xiao-Jing Song, Lei Zhang
Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef The Gut-Liver Axis in Cholestatic Liver Diseases
Andreas Blesl, Vanessa Stadlbauer
Nutrients.2021; 13(3): 1018. CrossRef Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang
Nutrients.2021; 13(3): 1013. CrossRef Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
Giovanni Targher, Herbert Tilg, Christopher D Byrne
The Lancet Gastroenterology & Hepatology.2021; 6(7): 578. CrossRef CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload
Riina Harjumäki, Chris S. Pridgeon, Magnus Ingelman-Sundberg
International Journal of Molecular Sciences.2021; 22(15): 8221. CrossRef Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim
World Journal of Gastroenterology.2021; 27(37): 6161. CrossRef Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
C Wendy Spearman, Mary Afihene, Omolade Betiku, Bilal Bobat, Lina Cunha, Chris Kassianides, Leolin Katsidzira, Hailemichael D Mekonnen, Ponsiano Ocama, Olusegun Ojo, Imran Paruk, Christian Tzeuton, Mark W Sonderup
The Lancet Gastroenterology & Hepatology.2021; 6(12): 1036. CrossRef Diet-Regulating Microbiota and Host Immune System in Liver Disease
Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min
International Journal of Molecular Sciences.2021; 22(12): 6326. CrossRef Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
Li-Hong He, Dun-Han Yao, Ling-Yun Wang, Lei Zhang, Xue-Li Bai
Frontiers in Microbiology.2021;[Epub] CrossRef INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE
Natalia O. Nosko, Viacheslav V. Kharchenko
Wiadomości Lekarskie.2021; 74(10): 2593. CrossRef Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis
Andrea D. Kim, Sung Eun Kim, Aleksandra Leszczynska, Benedikt Kaufmann, Agustina Reca, Dong Joon Kim, Ariel E. Feldstein
Scientific Reports.2021;[Epub] CrossRef Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos
World Journal of Hepatology.2021; 13(11): 1777. CrossRef
|